2023
DOI: 10.1002/cpp.2901
|View full text |Cite
|
Sign up to set email alerts
|

Psychotherapy for patients with schizotypal personality disorder: A scoping review

Kåre Donskov Nielsen,
Oliver Rumle Hovmand,
Mie Sedoc Jørgensen
et al.

Abstract: BackgroundTreatment of schizotypal personality disorder is complex. Currently, there are no clear evidence‐based recommendations for use of psychotherapy for individuals suffering from this mental illness, and studies are sparse. Our aim in this review is to map and describe the existing research and to answer the research question: What do we know about the use of psychotherapy for people with schizotypal personality disorder?MethodsWe conducted a scoping review using systematic searches in the Embase, MEDLIN… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…The Orygen Institute's program in Australia, which is dedicated to teenagers and young adults with first-episode psychosis with cooccurring disorders, would be a good example of such integrated initiatives. The evidence base pertaining to Cluster A PDs and treatment is extremely limited (for both pharmacology and psychotherapy), preventing any definitive recommendations (Kirchner et al, 2018;Nielsen et al, 2023); nonetheless, more research would help identifying if treatment might reduce the conversion rate to schizophrenia (Hjorthøj et al, 2018;Nielsen et al, 2023). More precise recommendations for handling schizotypal PD in practice might be available following the publication of an upcoming systematic review (Gundersen et al, 2023).…”
Section: Both Pd and Psychotic Symptoms Should Be Handled Jointlymentioning
confidence: 99%
“…The Orygen Institute's program in Australia, which is dedicated to teenagers and young adults with first-episode psychosis with cooccurring disorders, would be a good example of such integrated initiatives. The evidence base pertaining to Cluster A PDs and treatment is extremely limited (for both pharmacology and psychotherapy), preventing any definitive recommendations (Kirchner et al, 2018;Nielsen et al, 2023); nonetheless, more research would help identifying if treatment might reduce the conversion rate to schizophrenia (Hjorthøj et al, 2018;Nielsen et al, 2023). More precise recommendations for handling schizotypal PD in practice might be available following the publication of an upcoming systematic review (Gundersen et al, 2023).…”
Section: Both Pd and Psychotic Symptoms Should Be Handled Jointlymentioning
confidence: 99%
“…The following articles in this Special Issue are focused on evidence‐based psychotherapy on patients with personality disorders. In the first study (Nielsen et al, 2023), a scoping review was conducted to identify relevant existing psychotherapy research with patients with schizotypal personality disorder. Unfortunately, very few relevant studies have been conducted with this group of patients and results are inconclusive.…”
mentioning
confidence: 99%